Efficacy Evaluation of a Food Containing Lactic Acid Bacteria to ocular and nasal symptoms of allergy
- Conditions
- none
- Registration Number
- JPRN-UMIN000046503
- Lead Sponsor
- TES Holdings Co., Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 70
Not provided
1. Individuals who have some diseases with drug therapy. 2. Individuals who use antiallergic drugs or steroid drugs or will use during the test period. 3. Individuals who have history of intranasal laser therapy or sublingual immunotherapy to reduce allergic symptoms. 4. Individuals who are a patient of or have a history of asthma. 5. Individuals who are patient or have a history of mental disease, psychiatric disease, high blood pressure, diabetes, and hyperlipidemia. 6. Individuals who consecutively receive drugs for treatment of disease in the last 1 month. 7. Individuals who could have severe allergy to foods or drugs. 8. Individuals who have severe disease histories in liver, kidney, heart, lung, blood or the other tissues. 9. Individuals who are a patient or have a history of endocrine disease. 10. Individuals whose BMI is over 30 kg/m2 11. Individuals who have donated over 200 mL of blood in the last 1 month or 400 mL of blood in the last 3 months. 12. Individuals who cannot stop to ingest yogurt, or drugs or supplements including Lactic acid bacteria or bifidobacterium during the test period. 13. Individuals who had a habit to ingest bifidobacterium-rich foods, health-promoting foods, health foods, or supplements containing similar composition with a test food or will ingest those foods during the test period. 14. Individuals who generally intake alcohol drinks over 60 g/day as the amount of pure alcohol. 15. Individuals who could change their location and their life style during the study, e.g. business trip or traveling for a long time. 16. Individuals who are pregnant, breastfeeding, or planning to be pregnant in the near future. 17. Individuals who participated in other clinical trials in the last 3 months. 18. Individuals who and whose family work for a company manufacturing or selling healthy foods, functional foods. 19. Individuals who are judged unsuitable for this study by the investigator for other reasons.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method